A vial of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine candidate is seen in an undated photograph. Johnson & Johnson/Handout via REUTERS.
NEW YORK (Reuters) - Johnson & Johnson's one-shot COVID-19 vaccine received U.S. authorization on Saturday and will start being administered to Americans within days.
The following is how it fits into the vaccination effort with the two other authorized immunizations from Pfizer Inc/BioNTech SE and Moderna Inc.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
